🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/08/2025 | 80,11 | 81,17 | 80,11 | 80,69 | +0,40% | 1,32% | 6.882.900 |
| 07/08/2025 | 79,65 | 80,82 | 78,65 | 80,37 | +1,17% | 2,72% | 10.830.100 |
| 06/08/2025 | 80,29 | 81,32 | 79,27 | 79,44 | -1,67% | 2,55% | 13.028.700 |
| 05/08/2025 | 79,90 | 81,13 | 79,57 | 80,79 | +1,16% | 1,95% | 9.984.300 |
| 04/08/2025 | 79,06 | 79,99 | 78,43 | 79,86 | +0,72% | 1,97% | 13.380.700 |
| 01/08/2025 | 78,02 | 79,87 | 77,53 | 79,29 | +1,50% | 3,00% | 11.900.300 |
| 31/07/2025 | 80,80 | 81,49 | 77,85 | 78,12 | -4,44% | 4,50% | 19.813.300 |
| 30/07/2025 | 82,91 | 83,58 | 81,52 | 81,75 | -1,06% | 2,48% | 13.055.200 |
| 29/07/2025 | 79,85 | 82,89 | 76,66 | 82,63 | -1,70% | 7,80% | 27.826.400 |
| 28/07/2025 | 84,47 | 84,97 | 83,87 | 84,06 | -0,77% | 1,30% | 12.882.000 |
| 25/07/2025 | 84,16 | 85,22 | 83,84 | 84,71 | +0,71% | 1,64% | 10.058.800 |
| 24/07/2025 | 84,20 | 84,51 | 83,52 | 84,11 | +0,15% | 1,18% | 8.016.700 |
| 23/07/2025 | 82,62 | 84,14 | 82,41 | 83,98 | +2,90% | 2,09% | 11.542.100 |
| 22/07/2025 | 79,87 | 81,77 | 79,87 | 81,61 | +2,90% | 2,38% | 10.571.000 |
| 21/07/2025 | 80,16 | 80,31 | 78,95 | 79,31 | -0,81% | 1,70% | 11.620.800 |
| 18/07/2025 | 81,70 | 81,92 | 79,86 | 79,96 | -1,91% | 2,52% | 11.823.600 |
| 17/07/2025 | 81,98 | 82,66 | 81,34 | 81,52 | -1,10% | 1,61% | 8.984.800 |
| 16/07/2025 | 81,46 | 82,64 | 81,46 | 82,43 | +1,12% | 1,45% | 11.517.800 |
| 15/07/2025 | 83,78 | 84,36 | 81,30 | 81,52 | -2,57% | 3,65% | 10.827.000 |
| 14/07/2025 | 83,43 | 84,30 | 83,11 | 83,67 | +0,37% | 1,43% | 10.368.700 |
| 11/07/2025 | 84,02 | 84,13 | 82,26 | 83,36 | -0,79% | 2,23% | 9.717.400 |
| 10/07/2025 | 83,64 | 85,00 | 83,17 | 84,02 | +0,37% | 2,19% | 14.725.600 |
| 09/07/2025 | 82,38 | 84,48 | 81,89 | 83,71 | +2,88% | 3,14% | 18.394.600 |
| 08/07/2025 | 80,94 | 82,38 | 80,34 | 81,37 | +0,58% | 2,52% | 12.752.900 |
| 07/07/2025 | 80,95 | 81,54 | 80,15 | 80,90 | -0,04% | 1,72% | 15.777.400 |
| 03/07/2025 | 82,55 | 82,60 | 80,70 | 80,93 | -1,77% | 2,30% | 7.734.500 |
| 02/07/2025 | 82,06 | 82,81 | 81,89 | 82,39 | +0,71% | 1,12% | 16.052.700 |
| 01/07/2025 | 78,96 | 83,07 | 78,60 | 81,81 | +3,35% | 5,66% | 21.800.800 |
| 30/06/2025 | 79,25 | 79,39 | 78,38 | 79,16 | +0,08% | 1,27% | 13.895.200 |
| 27/06/2025 | 79,06 | 79,54 | 78,14 | 79,10 | +0,34% | 1,77% | 60.202.500 |